Articles by James Calloway
CoreWeave Faces $66.8B Backlog Test as Q1 Earnings Loom
CoreWeave reports Q1 earnings after the close May 7, with a $66.8B backlog and major deals with Meta, Anthropic, and Jane Street. Investors eye execution risks.
Uber's Strong Bookings Forecast Puts Pressure on Lyft Ahead of Earnings
Uber forecast Q2 gross bookings of $56.25-$57.75B, above estimates, after a Q1 revenue miss. Shares rose ~8% premarket. Lyft reports after Thursday's close.
Verizon Shifts Strategy: Ends Blanket Free Phone Offers, Targets Retention
Verizon CEO Dan Schulman ends blanket free phone and line offers, shifting to targeted retention. The carrier added 55,000 postpaid subscribers in Q1, its first positive Q1 since 2013.
Novo Nordisk Shares Surge on Strong Wegovy Pill Sales, Upgraded 2026 Outlook
Novo Nordisk raised its 2026 guidance after Wegovy pill prescriptions topped 2 million, sending shares up 9.2%. The company now expects a smaller decline in sales and profit this year.
Palantir Stock Dips Despite Record Q1 as U.S. Commercial Revenue Misses Estimates
Palantir shares dropped 6.9% on Tuesday after U.S. commercial revenue fell short of analyst expectations, overshadowing record Q1 results and an increased 2026 outlook.
Tesla Recalls 218,868 Vehicles in US; European FSD Approval Stalls
Tesla recalls 218,868 US vehicles over rearview camera delay. Stock slips 0.8% as European FSD approval faces regulatory hurdles.
Transocean Shares Drop 9% Despite $1.6B in New Contracts
Transocean shares fell 9.16% after reporting an adjusted Q1 loss of $28 million, despite $1.6 billion in new contracts. The DOJ's second request for the Valaris deal adds regulatory uncertainty.
Occidental Petroleum Q1 Profit Tops Estimates, Debt Reduction in Focus
Occidental Petroleum reported Q1 adjusted EPS of $1.06, above expectations, as US production rose. The company reduced debt to $13.3 billion and lowered its full-year production forecast. CEO transition planned for June 1.
Klaviyo Beats Q1 Estimates, CFO Departure Weighs on Shares
Klaviyo shares dropped 19% in after-hours trading despite beating Q1 estimates, as CFO Amanda Whalen's planned exit overshadowed strong results and a raised 2026 outlook.
FINRA Probes Morgan Stanley's Budapest Analyst Program Over Licensing
FINRA is investigating Morgan Stanley's Budapest analyst program after a whistleblower alleged unlicensed work on US and European deals and client data mishandling.
Astera Labs Surges on AI Revenue Beat, Switch Debut Next
Astera Labs beat Q1 estimates with revenue up 93% to $308.4M and issued strong Q2 guidance. Shares rose 1.27% after hours as the company begins shipping its Scorpio X-Series AI switch.